Welcome to The Infusion Center at Denver Arthritis Clinic, where we are dedicated to delivering exceptional care tailored to your unique needs.
Our state-of-the-art facility offers a comprehensive range of infusion therapies designed to treat a variety of conditions, ensuring our patients receive the most effective and up-to-date treatments available. Whether you are managing osteoporosis, inflammatory bowel diseases, multiple sclerosis, dermatological conditions, or autoimmune diseases, our skilled team is here to support you every step of the way.
At the Infusion Center, we prioritize your health and comfort, offering expert care in a convenient and welcoming environment. Let us partner with you on your journey to better health and improved quality of life.
Infliximab is a biologic medication used to treat various forms of arthritis, including rheumatoid arthritis and psoriatic arthritis. By targeting and neutralizing tumor necrosis factor-alpha (TNF-alpha), this infusion helps reduce inflammation and halt disease progression. Infliximab offers the advantage of improved joint function and pain relief for many patients.
Simponi Aria is an intravenous infusion therapy designed to treat rheumatoid arthritis and ankylosing spondylitis. By inhibiting TNF-alpha, it reduces inflammation and alleviates joint pain and stiffness. This medication is notable for its convenience, as it is administered once every eight weeks after the initial doses, making it a suitable option for long-term management.
Actemra, also known as tocilizumab, is used to treat moderate to severe rheumatoid arthritis. It works by inhibiting the interleukin-6 (IL-6) receptor, which plays a role in the inflammatory process. Actemra is effective in reducing symptoms and preventing joint damage, offering patients improved quality of life and function.
Orencia is a biologic infusion that helps manage rheumatoid arthritis by inhibiting T-cell activation, a critical step in the inflammatory response. It is particularly beneficial for patients who have not responded adequately to other treatments. Orencia is known for its ability to slow disease progression and enhance physical function.
Rituximab is an infusion therapy used primarily for rheumatoid arthritis patients who have not found relief with TNF inhibitors. It targets CD20-positive B cells, which are part of the immune system that contributes to inflammation. Rituximab is recognized for its effectiveness in reducing symptoms and long-lasting impact on disease activity.
Reclast is a bisphosphonate infusion designed to treat osteoporosis by stabilizing bones and reducing the risk of fractures. Administered once a year, it inhibits bone resorption, making it an effective option for patients looking for a long-term solution to maintain bone health.
Zometa is another bisphosphonate used primarily for managing bone complications associated with cancer but can also treat osteoporosis. It works by slowing down bone loss, providing structural support, and minimizing the risk of fractures, especially beneficial for those with severe bone density issues.
Boniva is a bisphosphonate infusion that helps increase bone mass and strength, primarily used in the treatment of osteoporosis in postmenopausal women. It is typically administered every three months, providing a convenient schedule for maintaining bone density and reducing fracture risk.
Prolia is a monoclonal antibody given as an injection every six months to treat osteoporosis. It works by inhibiting the development of osteoclasts, the cells responsible for bone breakdown, thus enhancing bone strength and reducing the likelihood of fractures, especially in individuals at high risk.
Evenity is a bone-building medication that not only slows bone loss but also promotes new bone formation. Administered monthly for up to a year, Evenity is particularly effective for those with a high risk of fracture, offering dual benefits of increasing bone mass and reducing fracture incidence.
Entyvio is a biologic infusion therapy specifically designed to treat inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. It works by selectively targeting the gut, reducing inflammation, and helping to manage symptoms effectively. Entyvio is known for its gut-specific action, minimizing systemic side effects and providing relief for patients who have not responded to other treatments.
Stelara is an infusion medication used to treat moderate to severe Crohn's disease and ulcerative colitis. By targeting interleukin-12 and interleukin-23, it helps to control inflammation and decrease disease activity. Stelara offers patients the benefit of extended dosing intervals, which can enhance compliance and improve quality of life by reducing the frequency of administration.
Ocrevus is an infusion medication used for treating relapsing and primary progressive forms of multiple sclerosis (MS). It works by targeting and depleting CD20-positive B cells, which are involved in the autoimmune response that damages myelin in MS. Ocrevus is recognized for its effectiveness in reducing relapses and slowing disease progression, offering patients improved management of symptoms and better quality of life.
Briumvi is a novel infusion therapy for multiple sclerosis, focusing on relapsing forms of the disease. It functions by selectively targeting B cells, helping to reduce inflammation and prevent further neurological damage. Briumvi is noted for its potential in decreasing the frequency of MS relapses and slowing the progression of disability, providing an important treatment option for patients seeking to manage their condition effectively.
Cosentyx is a biologic infusion therapy primarily used to treat moderate to severe plaque psoriasis and other dermatological conditions like psoriatic arthritis. It works by targeting interleukin-17A, a key cytokine involved in inflammation and the development of psoriasis symptoms. Known for its rapid effectiveness in clearing skin and improving joint symptoms, Cosentyx offers patients significant relief from the chronic discomfort associated with these conditions, often leading to improved quality of life.
Benlysta is a biologic infusion medication specifically designed for the treatment of lupus. It works by targeting and inhibiting the activity of a specific protein in the immune system known as BLyS, which is believed to contribute to abnormal B cell activity in lupus patients. By reducing this activity, Benlysta helps to manage symptoms, decrease flare-ups, and improve the overall quality of life for those living with lupus.
Saphnelo is an innovative infusion therapy for lupus, particularly effective in controlling systemic lupus erythematosus (SLE). It targets the type I interferon receptor, a key driver of lupus pathogenesis, helping to reduce inflammation and disease activity. Saphnelo is noted for its potential to decrease lupus flares and improve symptoms, offering a valuable option for patients seeking better disease management.
Krystexxa is an infusion medication used for treating severe, chronic gout. It works by converting uric acid into a harmless substance, which is then easily eliminated by the body, thereby lowering uric acid levels significantly. Krystexxa is particularly beneficial for patients who have not responded to conventional gout treatments, providing effective relief from painful symptoms and preventing further joint damage.
Solu-Medrol is an intravenous steroid used to treat inflammatory conditions such as lupus and vasculitis. As a corticosteroid, it reduces inflammation and suppresses the immune response, helping to alleviate symptoms and manage disease activity. Solu-Medrol is often used for acute flare-ups, providing rapid relief and helping to stabilize patients during severe episodes of inflammation.
Tepezza is an FDA-approved treatment for Thyroid Eye Disease, a condition where the immune system attacks the tissues and muscles around the eyes. This can cause swelling, redness, and bulging of the eyes, leading to vision changes and discomfort. Tepezza works by targeting a specific protein involved in this autoimmune response, helping to reduce inflammation and improve eye symptoms.
Vyepti is a new medication approved by the FDA for the treatment of migraines. It works by targeting a protein involved in pain signaling, helping to reduce the frequency and severity of migraine attacks. This once-a-month infusion can provide relief for those who suffer from chronic migraines, allowing them to better manage their symptoms and improve their overall quality of life.
Nulojix is a medication used in kidney transplant patients to prevent the body from rejecting the transplanted organ. It works by suppressing the immune system, reducing the risk of rejection and allowing the new organ to function properly. This medication is typically given as an infusion every two weeks for several months following a transplant surgery. While it may have side effects such as nausea and headaches, Nulojix has been shown to be effective in helping kidney transplant recipients maintain their new organ for longer periods of time.
Leqvio is a medication used to treat hyperlipidemia, or high levels of fat in the blood. It works by targeting specific proteins that play a role in cholesterol production, helping to lower LDL cholesterol levels and reducing the risk of heart disease. This medication is administered as an injection once every three months and has been shown to be effective in lowering cholesterol levels in patients with hyperlipidemia.
